Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients
Clinical trial NCT01817868 · COMPLETED
Trial details
- NCT number
- NCT01817868
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-01-04
- Primary completion
- 2018-07-16
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.